MediChain gives patients ownership of their own medical data. MediChain is a Medical Big-Data Platform. It allows patients to store their own data in a secure way and gives access to specialists anywhere regardless of the payer network or EMR (Electronic Medical Record) used.
MediChain is a Medical Big-Data Platform. Our proposed system allows patients to store their own data off-chain in an appropriate geographic domain, and give access to doctors and specialists anywhere, regardless of the payer network or EMR used.
Patients, doctors, and hospitals could put data into a compliant cloud which becomes part of the MediChain ecosystemand the blockchain stores pointers and rules on usage and anonymity, while the data itself is stored off-chain in a compliant cloud.
Patients could access their data at any time and allow other doctors and hospitals to access selected parts of the data transcending individual electronic medical records systems.
Researchers and Pharmaceutical companies would access the data as big data in fully anonymised form. It is monetized by the ability to voluntarily give anonymised access to untampered data to pharmaceutical companies, researchers and insurers. Potentially it may also be used for prescription management.
Its unique architecture allows fast access and small downloads to make it practical for everyday medical use. The protocol is based on smart cards (optional), Homomorphic encrypted access rules tables, json data formats, lightweight and strong cryptography and blockchain technology, which brings enhanced transparency and reliability in medical data exchange at every level, from devices to EMR to unprecedented opportunities for privatised big data sharing.
The protocol enables connections between patients, service providers, and medical researchers located anywhere in the world, regardless of systems used so long as the systems can work with the almost universal and open json format.
By improving patient data sharing and availability, and being open to add to any existing system or be managed automatically by doctor or by patient, MediChain aims to allow better conditions for all parties, creating a better way of handling patient data than anything available today.
By including different levels of access in rules MediChain seeks to neutralize the patient’s risk and increase their benefits.
Success Coach to Blockchain Startup Project Teams. Rated on Mar 13, 2018
4
4
4
9%
While I believe the team is strong and fully capable of a successful project, The medical system in developed countries already has patient information systems that may not be great, but are institutionalized. It will take a great deal of effort to be successful. However; after the provision of additional data by the project team I now believe they have to tools, resources and drive to make this work.
Icodriver...expert launching ICOs, Influencer, IT expert. Rated on Feb 7, 2018
2
2
2
9%
All I can see is these guys have chosen a name very similar to a major ICO in order to create confusion among the community. There is nothing original about this company and I don’t see a strong team, vision or product. I have been through their Telegram and watched the responses. They are clearly misleading their community and doing the work of a sophisticated scammer. No team member or advisor has any connections to healthcare. I would avoid at all costs.
Agree
7 people agree
Fred FooksICO team member replied on 26 Feb 2018
Our name has been publicly used since at least summer 2016, which is easily verified by checking Google or even our Twitter account.
Team: check our website at medichain.online. Our CEO and founder has the highest level of academic degree (a D.Phil) awarded by arguably the world leading institution in medical science:
http://www.ox.ac.uk/news/2016-09-29-medicine-oxford-named-worlds-best-sixth-year-running with experience in the world's highest rated healthcare system http://www.bbc.co.uk/news/health-40608253.
The team, of course also includes medical field and electronic healthcare record experts. This is also reflected on our website.
Differentiators: MediChain is the only system designed by people with experience in big data on this scale, pharmaceutical drug development and medical research over a number of key fields.
That means that unlike other solutions, which are essentially just blockchain adapted Electronic Health Record solutions, MediChain is a powerful blockchain big data solution by design.
This is MediChain's USP and in doing that, there are eight areas of application of analytics which can improve healthcare: 1) predictive modelling for risk and resource use; 2) population management; 3) drug and medical device safety surveillance; 4) disease and treatment heterogeneity; 5) precision medicine and clinical decision support; 6) quality of care and performance measurement; 7) public health; and research applications. Predictive analytics using big data technology is technology that learns from experience (data) to predict the future behavior of individuals in order to drive better decisions (, i.e., future insights), based on a full picture of associations, for example, across time or a wide geographic area, or observed in a substantial fraction of entire population.
These benefits not only help patients worldwide but make MediChain a natural partner to #ehr and #emr providers rather than a rival in a crowded and highly established market.
One of the great limits to using blockchain in medical data applications is speed. While systems like Visa card processing handle: 24,000 transactions each second, Ethereum can only handle 20 transactions per second. Even the innovative Ripple can only handle 1,500 transactions each second. To overcome this, #MediChain are working on a patent- pending system designed by Mark Baker to allow parallel processing of the medical blockchain, to speed up transactions up to a theoretical increase of 14,400 times with the data planned. MediChain’s approach may allow the speed that will outpace even state- of- the- art systems like Visa - but for medical data.
The MediChain data project has been in talks with national level medical projects and specialist departments all over the world including Rheumatology, Alzheimer's, Epilepsy, as well as a major provider of Electronic Records Systems and major research institutes in · Heart Disease, Alzheimer's Disease, Blindness, Arthritis and Cystic Fibrosis. They expect to announce over a dozen collaborative big data programmes with major institutions from Q2 2018 onward
ox.ac.uk
Medicine at Oxford named world's best for sixth year running | University of Oxford
Medical and health teaching and research at Oxford University has been ranked as the world's best for the sixth year running in the Times Higher Education World University Rankings.
http://www.ox.ac.uk/sites/files/oxford/field/field_image_main/medical_school_main.jpg
BBC News
NHS ranked 'number one' health system
But study of 11 nations raises concerns about quality of care in UK despite praising efficiency and affordability.
https://ichef-1.bbci.co.uk/news/1024/branded_news/E40F/production/_93938385_istock-501707098.jpg
Co-Founder & President at Koinsquare | Marketing Manager at AidCoin | Campaign Success Manager at 200 Crowd | Advisory Board Member Rated on May 9, 2018
4
4
4
8%
Nice project, I believe that blockchain could really be a plus with it!
Blockchain Investor, Early Miner and CryptoCurrency Evangelist Rated on Feb 20, 2018
4
4
3
1%
This ICO looks good, Team is capable and advisers have some good names, including tech crunch co-founder.
Also, product category is good and health care is the prominent area for blockchain usability.
Experts are independently and voluntarily contributing to the community. If no expert has rated the ICO, only ICO analyzer's results are used. Always research before investing as these ratings should not be taken as an investing guide of any kind.
Ratings and ICO analyzer results are being updated (re-calculated) every few hours.
